Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data

Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data

Abstract Background Stratification of patients with severe asthma by blood eosinophil counts predicts responders to anti-interleukin (IL)-5 (mepolizumab and reslizumab) and anti-IL-5 receptor α (benralizumab) therapies. This study characterized patients with severe asthma who could qualify for these...

Full description

Bibliographic Details
Main Authors: Don Husereau, Jason Goodfield, Richard Leigh, Richard Borrelli, Michel Cloutier, Alain Gendron
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Asthma
Severe
Eosinophilia
Interleukin-5
Online Access:http://link.springer.com/article/10.1186/s13223-018-0241-1

Internet

http://link.springer.com/article/10.1186/s13223-018-0241-1

Similar Items